World's Best Scientists 2026 revealed!
Therapeutic Advances in Respiratory Disease
H-index 14

Therapeutic Advances in Respiratory Disease

1753-4658

Published by: SAGE

https://journals.sagepub.com/home/tar

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1972 59 92 12

Additional Metrics

Number of Best Scientists*: 107
Documents by Best Scientists*: 166
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 59
SCIMAGO SJR: 1.009
Impact Factor: 3.2

Overview

Top Research Topics at Therapeutic Advances in Respiratory Disease?

The journal explores disciplines such as Internal medicine, Intensive care medicine, COPD, Asthma and In patient. Therapeutic Advances in Respiratory Disease focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology, Oncology and Cardiology. The Oncology works, particularly on Lung cancer are tackled in the journal.

It dives deep in exploring the relationship between the study of Lung cancer and Cancer research. Issues in Intensive care medicine were discussed, taking into consideration concepts from other disciplines like Psychological intervention, Clinical trial, Pneumonia, Pharmacotherapy and Disease. It explores topics in COPD which can be helpful for research in disciplines like Anesthesia, Pulmonary disease, Exacerbation, Physical therapy and Bronchodilator.

Asthma research discussed in Therapeutic Advances in Respiratory Disease aim to provide more information in the subject of Immunology. The journal connects research in Immunology with the related topic of Lung.

  • Internal medicine (30.17%)
  • Intensive care medicine (25.42%)
  • COPD (20.85%)

What are the most cited papers published in the journal?

  • The pathogenesis of idiopathic pulmonary fibrosis. (207 citations)
  • The airway epithelium: more than just a structural barrier (157 citations)
  • C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. (137 citations)

Research areas of the most cited articles at Therapeutic Advances in Respiratory Disease:

The journal publications tackle a plethora of topics, such as Immunology, COPD, Intensive care medicine, Internal medicine and Asthma. Issues in COPD were discussed in the most cited articles, taking into consideration concepts from other disciplines like Pulmonary disease, Physical therapy, Lung and Disease. While Intensive care medicine is the focus of the most cited papers, it also provides insights into the studies of Exacerbation and Pneumonia.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

Therapeutic Advances in Respiratory Disease mostly deals with topics like Internal medicine, COPD, 2019-20 coronavirus outbreak, Lung and Asthma. It focuses on Internal medicine as well as the interrelated topic of Oncology. The studies in COPD featured incorporate elements of Pulmonary disease, Patient satisfaction and Fluticasone propionate.

Therapeutic Advances in Respiratory Disease addresses concerns in Lung which are intertwined with other disciplines, such as Ivacaftor, Cystic fibrosis transmembrane conductance regulator and Intensive care medicine. It features studies on Intensive care medicine, including topics such as Polypharmacy. Asthma research featured in Therapeutic Advances in Respiratory Disease incorporates concerns from various other topics such as Airway and Family medicine.

The most cited articles from the last journal are:

  • Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study. (4 citations)
  • Three-month outcomes of recovered COVID-19 patients: prospective observational study. (3 citations)
  • Respiratory viral infections in the elderly. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Therapeutic Advances in Respiratory Disease (based on the number of publications) are:

  • Marc Miravitlles (12 papers) absent at the last edition,
  • Mario Cazzola (10 papers) absent at the last edition,
  • François Maltais (8 papers) absent at the last edition,
  • Murat Songu (6 papers) absent at the last edition,
  • Kyeongman Jeon (6 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutic Advances in Respiratory Disease (based on the number of publications) are:

  • AstraZeneca (12 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Baylor College of Medicine (10 papers) absent at the last edition,
  • University of Rome Tor Vergata (10 papers) absent at the last edition,
  • Guangzhou Medical University (8 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Seconda Università degli Studi di Napoli (8 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.26% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.56% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.44% of all publications and 53.33% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Respiratory Disease Research

Individuals with extensive knowledge and a background in respiratory diseases often find lucrative careers in the field of healthcare. Specifically, nurses specializing in respiratory diseases can see a high demand in medical facilities across North Dakota. Those interested in such careers need to be aware of the specific educational and professional requirements involved. In North Dakota, for example, and similar to many other states, nurses must first complete a registered nursing program and pass the NCLEX-RN exam. However, to specialize in respiratory diseases, additional education and training may be necessary. Those interested in this field can obtain more details about the required nursing education and professional training from the appropriate sources. If you're interested in pursuing a rewarding career in healthcare specifically related to respiratory diseases, take a look at the north dakota nursing license requirements to understand the education and professional training requirements. Hence, a career in the treatment and research of respiratory diseases can be rewarding, both in the context of personal satisfaction and financial compensation. Furthermore, such roles are crucial in our society, as they contribute significantly to the well-being and health of the population.

Top Publications

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking alternative or complementary career options, there are several related online degrees and certifications to consider. An online PhD nursing offers advanced clinical and leadership roles, bridging the gap between direct patient care and healthcare administration.

Another critical area within healthcare is medical coding and billing. Many reputable programs provide access to medical billing and coding schools online, often with financial aid options. This path allows professionals to work behind the scenes ensuring accurate healthcare documentation and reimbursement.

Additionally, not all medical careers require a medical degree. Graduates can explore high-paying jobs with a biology degree that leverage foundational science knowledge in research, pharmaceuticals, or public health.

For those focusing on coding specialization, understanding differences between CPC and CCS certifications is crucial. The certified professional coder credential can significantly impact salary prospects and job opportunities in healthcare administration.

Best Scientists Contributing to This Journal

Recently Published Articles